Evidence map›Paper›PMID 27559011›Full record

ArticleScientific reports2016

Patterning nanofibrils through the templated growth of multiple modified amyloid peptides.

Hiroki Sakai, Ken Watanabe, Fuki Kudoh, Rui Kamada, Yoshiro Chuman, Kazuyasu Sakaguchi

Abstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. The structure of a βNature communications · 2018
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hiroki SakaiDepartment of Chemistry, Faculty of Science, Hokkaido University, N10 W8, Kita-ku, Sapporo 060-0810, Japan.
Ken WatanabeDepartment of Chemistry, Faculty of Science, Hokkaido University, N10 W8, Kita-ku, Sapporo 060-0810, Japan.
Fuki KudohDepartment of Chemistry, Faculty of Science, Hokkaido University, N10 W8, Kita-ku, Sapporo 060-0810, Japan.
Rui KamadaDepartment of Chemistry, Faculty of Science, Hokkaido University, N10 W8, Kita-ku, Sapporo 060-0810, Japan.
Yoshiro ChumanDepartment of Chemistry, Faculty of Science, Hokkaido University, N10 W8, Kita-ku, Sapporo 060-0810, Japan.
Kazuyasu SakaguchiDepartment of Chemistry, Faculty of Science, Hokkaido University, N10 W8, Kita-ku, Sapporo 060-0810, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There has been considerable interest in the patterning of functionalized nanowires because of the potential applications of these materials to the construction of nanodevices. A variety of biomolecular building blocks containing amyloid peptides have been used to functionalize nanowires. However, the patterning of self-assembled nanowires can be challenging because of the difficulties associated with controlling the self-assembly of these functionalized building blocks. Herein, we present a versatile approach for the patterning of nanowires based on the combination of templated fibril growth with a versatile functionalization method using our structure-controllable amyloid peptides (SCAPs). Using this approach, we have succeeded in the formation of multi-type nanowires with tandem domain structures in high yields. Given that the mixing-SCAP method can lead to the formation of tandem fibrils, it is noteworthy that our method allowed us to control the initiation of fibril formation from the gold nanoparticles, which were attached to a short fibril as initiation points. This approach could be used to prepare a wide variety of fibril patterns, and therefore holds great potential for the development of novel self-assembled nanodevices.

Indexed as

Aluminum SilicatesAmino Acid SequenceAmyloidAmyloid beta-PeptidesGoldMetal NanoparticlesMicroscopy, Atomic ForceMicroscopy, FluorescenceNanowiresAluminum SilicatesAmyloidAmyloid beta-PeptidesGoldmica

Identifiers

PMID27559011
PMCPMC4997568

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.